Table 3.
Cox regression analysis for overall mortality with categorized SP controlled duration
| SP controlled duration | Unadjusted |
Adjusteda |
||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| 0 month | 1 (refer) | − | 1 (refer) | − |
| 1–11 months | 0.592 (0.324–1.080) | 0.087 | 0.598 (0.321–1.158) | 0.120 |
| 12–23 months | 0.228 (0.103–0.50l) | <0.001 | 0.197 (0.082–0.458) | <0.001 |
| 24–35 months | 0.231 (0.099–0.540) | 0.001 | 0.279 (0.114–0.683) | 0.005 |
| >35 months | 0.193 (0.092–0.403) | <0.001 | 0.143 (0.064–0.331) | <0.001 |
MAP and KT/V were calculated by formulas mentioned before. SP, serum phosphorus; HR, hazard ratio; CI, confidence interval; DKD, diabetic kidney disease; MAP, mean arterial pressure; GLUC, glucose concentration; ALB, albumin; HGB, hemoglobin.
a
Adjusted for demographics (age and sex), DKD to ESRD, and the mean values of MAP, dialysate GLUC, urine volume, serum ALB, HGB, and KT/V during the first 12 months after dialysis.